Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus

被引:109
|
作者
Rawshani, Aidin [1 ,2 ]
Rawshani, Araz [1 ,2 ]
Sattar, Naveed [4 ]
Franzen, Stefan [2 ,3 ]
McGuire, Darren K. [6 ]
Eliasson, Bjorn [2 ]
Svensson, Ann-Marie [2 ]
Zethelius, Bjorn [5 ]
Miftaraj, Mervete [2 ]
Rosengren, Annika [1 ]
Gudbjornsdottir, Soffia [2 ]
机构
[1] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden
[2] Swedish Natl Diabet Register, Ctr Registers Reg, Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Hlth Metr Unit, Gothenburg, Sweden
[4] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[5] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden
[6] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX USA
基金
瑞典研究理事会;
关键词
cardiovascular disease; cerebrovascular disorders; diabetes mellitus; type; 1; glycated hemoglobin A; heart failure; mortality; risk factors; PITTSBURGH EPIDEMIOLOGY; INSULIN-RESISTANCE; LOWERING THERAPY; GLYCEMIC CONTROL; DISEASE; HYPERTENSION; COMPLICATIONS; EUROPE;
D O I
10.1161/CIRCULATIONAHA.118.037454
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The strength of association and optimal levels for risk factors related to excess risk of death and cardiovascular outcomes in type 1 diabetes mellitus have been sparsely studied. METHODS: In a national observational cohort study from the Swedish National Diabetes Register from 1998 to 2014, we assessed relative prognostic importance of 17 risk factors for death and cardiovascular outcomes in individuals with type 1 diabetes mellitus. We used Cox regression and machine learning analyses. In addition, we examined optimal cut point levels for glycohemoglobin, systolic blood pressure, and low-density lipoprotein cholesterol. Patients with type 1 diabetes mellitus were followed up until death or study end on December 31, 2013. The primary outcomes were death resulting from all causes, fatal/nonfatal acute myocardial infarction, fatal/nonfatal stroke, and hospitalization for heart failure. RESULTS: Of 32 611 patients with type 1 diabetes mellitus, 1809 (5.5%) died during follow-up over 10.4 years. The strongest predictors for death and cardiovascular outcomes were glycohemoglobin, albuminuria, duration of diabetes mellitus, systolic blood pressure, and low-density lipoprotein cholesterol. Glycohemoglobin displayed approximate to 2% higher risk for each 1-mmol/mol increase (equating to approximate to 22% per 1% glycohemoglobin difference), whereas low-density lipoprotein cholesterol was associated with 35% to 50% greater risk for each 1-mmol/L increase. Microalbuminuria or macroalbuminuria was associated with 2 to 4 times greater risk for cardiovascular complications and death. Glycohemoglobin <53 mmol/mol (7.0%), systolic blood pressure <140 mm Hg, and low-density lipoprotein cholesterol <2.5 mmol/L were associated with significantly lower risk for outcomes observed. CONCLUSIONS: Glycohemoglobin, albuminuria, duration of diabetes mellitus, systolic blood pressure, and low-density lipoprotein cholesterol appear to be the most important predictors for mortality and cardiovascular outcomes in patients with type 1 diabetes mellitus. Lower levels for glycohemoglobin, systolic blood pressure, and low-density lipoprotein cholesterol than contemporary guideline target levels appear to be associated with significantly lower risk for outcomes.
引用
收藏
页码:1900 / 1912
页数:13
相关论文
共 50 条
  • [41] Incidence, risk factors and predictors of cardiovascular mortality for aortic stenosis among patients with diabetes mellitus
    Ko, Tsung-Yu
    Lin, Ting-Tse
    Hsu, Jung Chi
    Yang, Yen-Yun
    Chuang, Shu-Lin
    Lin, Lian-Yu
    Kao, Hsien-Li
    Ho, Yi-Lwun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 191
  • [42] Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study
    Spijkerman, AMW
    Dekker, JM
    Nijpels, G
    Jager, A
    Kostense, PJ
    van Hinsbergh, VWM
    Bouter, LM
    Heine, RJ
    Stehouwer, CDA
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (12) : 924 - 930
  • [43] Cardiovascular complications in type 1 diabetes mellitus
    Brindisi, M. -C.
    Bouillet, B.
    Verges, B.
    Halimi, S.
    DIABETES & METABOLISM, 2010, 36 (05) : 341 - 344
  • [44] Modern approaches to management of cardiovascular risk factors at patients with diabetes mellitus type 2
    Verbovoy, A. F.
    Pashentseva, A. V.
    Verbovaya, N. I.
    Madyanov, I. V.
    Sharonova, L. A.
    Galkin, R. A.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (08) : 113 - 117
  • [45] Cardiovascular Risk in Type 1 Diabetes Mellitus
    Schofield, Jonathan
    Ho, Jan
    Soran, Handrean
    DIABETES THERAPY, 2019, 10 (03) : 773 - 789
  • [46] Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study
    Preis, Sarah Rosner
    Pencina, Michael J.
    Hwang, Shih-Jen
    D'Agostino, Ralph B., Sr.
    Savage, Peter J.
    Levy, Daniel
    Fox, Caroline S.
    CIRCULATION, 2009, 120 (03) : 212 - U52
  • [47] Periodontal status and risk factors in patients with type 1 diabetes mellitus
    Costa, Rosana
    Rios-Carrasco, Blanca
    Lopez-Jarana, Paula
    Cabral, Cristina
    Cunha, Filipe
    Goncalves, Maria
    Relvas, Marta
    CLINICAL ORAL INVESTIGATIONS, 2025, 29 (02)
  • [48] All-cause mortality and its risk factors among type 1 and type 2 diabetes mellitus in a country facing diabetes epidemic
    Al-Rubeaan, Khalid
    Youssef, Amira M.
    Ibrahim, Heba M.
    Al-Sharqawi, Ahmad H.
    AlQumaidi, Hamid
    AlNaqeb, Dhekra
    Aburisheh, Khaled H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 118 : 130 - 139
  • [49] Cardiovascular Risk Factors Characteristic for the Metabolic Syndrome in Adult Patients with Type 1 Diabetes
    Nadas, J.
    Putz, Z.
    Fovenyi, J.
    Gaal, Z.
    Gyimesi, A.
    Hidvegi, T.
    Hosszufalusi, N.
    Neuwirth, G.
    Oroszlan, T.
    Panczel, P.
    Szeles, G.
    Vandorfi, G.
    Winkler, G.
    Wittmann, I.
    Jermendy, G.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2009, 117 (03) : 107 - 112
  • [50] Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China
    Zhou, Huanhuan
    Zhang, Chenghuan
    Ni, Jingyu
    Han, Xiaoyun
    BMC ENDOCRINE DISORDERS, 2019, 19 (01)